Core Viewpoint - 弘业期货's stock price has shown a year-to-date increase of 13.19%, but has recently experienced declines over various time frames, indicating potential volatility in its market performance [2]. Group 1: Stock Performance - As of November 18, 弘业期货's stock price decreased by 2.07% to 10.90 CNY per share, with a total market capitalization of 10.985 billion CNY [1]. - The stock has seen a decline of 1.27% over the last 5 trading days, 2.33% over the last 20 days, and 18.84% over the last 60 days [2]. - The company has appeared on the龙虎榜 (a stock trading leaderboard) 8 times this year, with the most recent appearance on July 14, where it recorded a net buy of 24.6763 million CNY [2]. Group 2: Financial Performance - For the period from January to September 2025, 弘业期货 reported zero operating revenue and a net profit attributable to shareholders of 2.0897 million CNY, reflecting a year-on-year decrease of 87.27% [3]. - Cumulative cash dividends since the A-share listing amount to 44.3422 million CNY [4]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 13.10% to 54,400, with an average of 0 circulating shares per shareholder [3]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 2.8647 million shares, a decrease of 3.2006 million shares from the previous period [4].

苏豪弘业期货股份有限公司（以下简称"公司"）于2025年8月20日在巨潮资讯网披 露了《关于控股股东之一致行动人拟减持公司股份的预披露公告》（公告编号：2025- 040），江苏省苏豪控股集团有限公司之一致行动人江苏苏豪汇鸿集团股份有限公司（以 下简称"苏豪汇鸿"）持有公司股份63,930,134股，持股比例为6.34%，控股股东苏豪控 股之一致行动人江苏弘业国际物流有限公司（以下简称"弘业物流"）持有公司股份 8,285,345股，持股比例为0.82%。苏豪汇鸿及弘业物流计划自公告披露之日起十五个交易 日后的三个月内以集中竞价交易合计减持本公司股份不超过10,077,777股（占总股本比例 1%），本次减持不会导致公司控制权发生变更。 证券代码：001236 证券简称： 公告编号：2025-056 2025年9月19日，公司披露了《关于控股股东之一致行动人权益变动后持股比例触及 1%整数倍的提示性公告》，苏豪汇鸿及弘业物流通过集中竞价方式累计减持公司股份 5,948,200股（占公司总股本比例为0.60%），具体内容详见公司发布的相关公告。 2025年11月17日，公司收到苏豪汇鸿及弘业物流出具的《关于减持 ...

Core Viewpoint - Hongye Futures has completed a share reduction plan, with a total of approximately 10.08 million shares, accounting for 1% of the company's total shares [1] Group 1: Share Reduction - Hongye Futures announced that the share reduction plan by Suhao Huihong and Hongye Logistics has been implemented [1] - The total shares reduced amounted to approximately 10.08 million [1] Group 2: Financial Performance - For the first half of 2025, the revenue composition of Hongye Futures is as follows: 29.79% from futures and options brokerage, 12.36% from customer fund deposits, 0.62% from asset management business, and 0.3% from repurchase agreements [1] - As of the report date, the market capitalization of Hongye Futures is 11.2 billion yuan [1]

Core Viewpoint - Hongye Futures has completed its share reduction plan, resulting in a total reduction of approximately 10.08 million A-shares [1] Group 1 - The company received a notification letter from Huihong Group and Hongye Logistics regarding the completion of the share reduction [1] - The share reduction plan has been fully implemented as of the date of the announcement [1]

Group 1 - The core point of the article is that Hongye Futures has completed its share reduction plan, resulting in a total reduction of approximately 10.08 million A-shares [1] Group 2 - The share reduction was executed by Huihong Group and Hongye Logistics, as indicated in the notification letter [1] - The announcement confirms that the share reduction plan has been fully implemented as of the date of the disclosure [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 就 因 本 公 告 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 Holly Futures （ 於 中 華 人 民 共 和 國 （ 「 中 國 」 ） 註 冊 成 立 的 股 份 有 限 公 司 ， 中 文 公 司 名 稱 蘇 豪 弘 業 期 貨 股 份 有 限 公 司（前稱弘業期貨股份有限公司） ， 在 香 港 以 Holly Futures 的 名 義 開 展 業 務 ) 關於控股股東之一致行動人減持計劃 完成公告 本 公 告 乃 本 公 司 根 據 香 港 聯 合 交 易 所 有 限 公 司（「聯交所」）證 券 上 市 規 則（「上 市 規 則」）第13.09條及香港法例第571章證券及期貨條例第XIVA部項下內幕消息條 文（如 上 市 規 則 所 定 義）發 出。 茲提述本公司日期為2025年8月19日 的 公 告（「該公告」），內 容 關 於 本 公 司 控 股 股 東 江 蘇 省 蘇 豪 控 股 集 ...

Core Viewpoint - 弘业期货 is a significant player in the futures market, being the first A+H share listed company in the industry, with a focus on various financial services including futures brokerage and asset management [2][7]. Company Overview - 弘业期货主要从事商品期货经纪、金融期货经纪、期货投资咨询、资产管理、基金销售和金融资产投资业务 [7]. - The company is controlled by the Jiangsu Provincial Government State-owned Assets Supervision and Administration Commission, indicating its status as a state-owned enterprise [3]. - As of September 30, 2025, 弘业期货 reported a revenue of 0.00 yuan and a net profit of 208.97 million yuan, reflecting a year-on-year decrease of 87.27% [7]. Financial Performance - The company achieved a trading volume of 1.25 billion yuan on November 17, with a market capitalization of 11.217 billion yuan [1]. - The average trading cost of the stock is 11.82 yuan, with the stock price nearing a resistance level of 11.44 yuan, suggesting potential for upward movement if the resistance is broken [6]. Shareholder Structure - As of September 30, 2025, the number of shareholders decreased by 13.10% to 54,400, with no circulating shares per capita [7]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited and Southern CSI 1000 ETF, with notable reductions in their holdings [8]. Investment Activities - 弘业期货 has invested 22 million yuan in 弘瑞新时代创业投资有限公司, holding a 22% stake, which focuses on venture capital and management consulting [2].

Core Insights - On November 14, Hongye Futures executed a block trade of 210,000 shares with a transaction value of 2.0958 million yuan, accounting for 1.23% of the total trading volume for the day [1][2] - The transaction price was 9.98 yuan, representing a discount of 9.85% compared to the market closing price of 11.07 yuan [1] Group 1: Transaction Details - The block trade occurred on November 14, 2025, involving the security code 001236, referred to as "引不明亮" [2] - The transaction volume was 210,000 shares, with a total transaction amount of 2.0958 million yuan [2] - The buyer was an institutional client, while the seller was from the Shanghai Pudong New Area, specifically the Chengshan Road Securities Business Department of Founder Securities Co., Ltd. [2]

Group 1 - Longjian Co., Ltd. won a bid for a highway maintenance project in Heilongjiang with a contract value of 483 million yuan, accounting for 2.64% of the company's expected revenue for 2024 [1] - Transsion Holdings plans to issue H-shares and list on the main board of the Hong Kong Stock Exchange [1] - Good Home's controlling shareholder intends to reduce its stake by up to 2.7%, equivalent to no more than 39.4468 million shares [1][2] Group 2 - Xinhua Insurance reported a cumulative premium income of 181.973 billion yuan from January to October, representing a year-on-year growth of 17% [2][4] - Zhejiang Jiaokao is part of a consortium that plans to bid for a new urbanization project with an estimated total investment of 11.103 billion yuan [4] Group 3 - Changchun High-tech received approval for clinical trials of a vaccine for adolescents and adults [6] - XinNuoWei's application for the listing of Pertuzumab injection has been accepted, targeting HER2-positive breast cancer [8] - Dash Smart won a bid for an intelligent project at the new Huanggang Port inspection building, valued at 55.056 million yuan, which is 1.74% of its expected revenue for 2024 [8] Group 4 - Electronic City is involved in a lawsuit for debt recovery, with the amount in dispute estimated at 777 million yuan [9] - Haibo Technology signed a strategic cooperation agreement with CATL for a cumulative procurement of no less than 200 GWh of electricity from 2026 to 2028 [10] Group 5 - Renfu Pharmaceutical's HW231019 tablets have entered the second phase of clinical trials for postoperative pain relief [11] - Tonghua Dongbao received a drug registration certificate for Aspart Insulin injection from the Dominican Republic [11] Group 6 - Shaanxi Construction reported winning major projects worth a total of 1.016 billion yuan in October [12] - Fuzhou Environmental Protection plans to change its stock name to "Fuzhou Technology" [12] Group 7 - Panlong Pharmaceutical's gel patch for knee osteoarthritis has received approval for clinical trials [15] - Zhongyida's application for a specific stock issuance has been terminated by the Shanghai Stock Exchange [16] Group 8 - Zhizhong Home's controlling shareholder reduced its holdings of convertible bonds by 905,000 units, accounting for 13.51% of the total issued [19] - Haibo Co., Ltd. plans to establish a subsidiary with an investment of 1 billion yuan for high-end component projects [21] Group 9 - Caina Co. plans to use 57 million yuan of idle funds to purchase structured deposits [23] - Zhendong Pharmaceutical's new drug for acute ischemic stroke has entered the IIa phase of clinical trials [25] Group 10 - Weiman Sealing's overseas subsidiary plans to lease a factory in Saudi Arabia for 5 years at a total rent of approximately 54.039 million yuan [26] - Yiling Pharmaceutical's application for Memantine Hydrochloride has been approved for market entry [28] Group 11 - Dongfang Zhizao plans to acquire 70% of Saifu Machinery for 27.4887 million yuan [30] - JianKai Technology's actual controller intends to transfer 3% of the company's shares through inquiry [31] Group 12 - Rejing Bio plans to repurchase shares worth between 100 million and 200 million yuan [32] - Bangji Technology has decided to terminate a major asset restructuring project due to failure to reach an agreement [34] Group 13 - Huadong Pharmaceutical's application for the marketing license of a new drug has been accepted [36] - Zhonggu Logistics' shareholder plans to reduce its stake by up to 3% [38] Group 14 - Bohui Innovation's subsidiary received approval for a clinical trial of a vaccine for invasive infections [40] - Shannon Chip's shareholder pledged 0.27% of the company's shares for financing [42] Group 15 - Shanghai Petrochemical appointed a new general manager [44] - Jiaojian Co. plans to reduce the holdings of some directors and executives by up to 0.35% [46] Group 16 - Weiting Electric plans to raise no more than 300 million yuan through a private placement [47] - Zhongjin Irradiation plans to invest approximately 200 million yuan in an electronic accelerator manufacturing project [49] Group 17 - Tongxing Technology signed a framework agreement to invest 3.2 billion yuan in a sodium battery project [50] - Hongri Da plans to establish a subsidiary focused on semiconductor packaging [51] Group 18 - Shanghai Kaibao's new drug for acute ischemic stroke has received approval for clinical trials [53] - Yitong Century announced a change in its control structure, becoming a company without a controlling shareholder [55]

Core Viewpoint - Hongye Futures (001236) announced that its controlling shareholder, Suhao Holdings Group, plans to reduce its stake through Zhongshan Company by selling up to 24.255 million H-shares starting from December 1 for a period of six months, representing a maximum reduction of 2.41% of the company's total issued shares [1] Group 1 - The planned share reduction will be executed via centralized bidding [1] - The maximum number of shares to be sold is 24.255 million [1] - The reduction period is set for six months starting from December 1 [1]